The Covid working group of National Technical Advisory on Immunisation (NTAGI) will review the data of Covovax manufactured by the Serum Institute of India (SII) this week for use in children and adults, a source said on Wednesday.
The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India s vaccine Covovax for use for children and adults, on April 1, sources informed on Wednesday.
The Covid working group of National Technical Advisory on Immunisation (NTAGI) will review the data of Covovax manufactured by the Serum Institute of India (SII) this week for use in children and adults, a source said on Wednesday.The source .